STOCKUPSIDE.IO
Analyst Price Target Intelligence
← Full Rankings
← Back to rankings
Ranked #960 by analyst upside · 2026-09-04
LGMK
LogicMark, Inc.
Healthcare · Market Cap $1M · P/E 0x
ANALYST PRICE TARGET
+80.0%
implied upside to consensus target
Current Price $1.25
Consensus Target $2.25
Bull Target $2.25
Bear Target $2.25
Analysts Covering 1
ANALYST CONSENSUS - HOLD
Strong Buy
0
Buy
0
Hold
1
Sell
0
52-Week Low $0.35
52-Week High $3.0
YTD Return +0.0%
FUNDAMENTALS
Market Cap $1M
P/E Ratio (TTM) N/A
Forward P/E N/A
EPS (TTM) $-4.95
PEG Ratio N/A
Dividend Yield N/A
Revenue (TTM) $13M
Profit Margin -49.6%
52-WEEK RANGE
52-Week Low $0.35
52-Week High $3.0
Current Price $1.25
Bear Target $2.25
Bull Target $2.25
● Now $1.25 ● Target $2.25
TRADING DATA
Avg Volume 5K
YTD Return +0.0%
Analyst Count 1
Consensus Hold
Upside to Target +80.0%
Last Updated 2026-09-04

ANALYST SUMMARY

LogicMark, Inc. (LGMK) is currently trading at $1.25 with a Wall Street consensus price target of $2.25, implying potential upside of 80.0% over the next 12 months. 1 analysts currently cover LGMK, with a consensus rating of Hold - 0% of analysts rate the stock a Buy or Strong Buy. The most bullish analyst has a price target of $2.25, while the most cautious has a target of $2.25.

LGMK operates in the Healthcare sector with a market capitalisation of $1M. The stock is up 0.0% year-to-date and is currently trading near the lower end of its 52-week range of $0.35 – $3.0.

SIMILAR STOCKS

Other Healthcare stocks with comparable size and valuation.

HISTORICAL SNAPSHOT

Point-in-time data from StockUpside's daily snapshots. Tracks price, analyst target, upside %, consensus, and analyst count.

Loading…
ANALYST CONVICTION SCORE
15
out of 100
Coverage depth
5/30
Consensus clarity
8/30
Vote unanimity
0/25
Rating stability
2/15

Measures analyst agreement, not fundamental quality. A high score means analysts broadly agree on this call - not that the stock will go up.

See 4,000+ stocks ranked by analyst upside

StockUpside.io tracks analyst consensus price targets across thousands of US-listed stocks, updated every day. The full ranked list is available with a Pro subscription.

View Full Rankings →